Different mechanisms have been proposed to explain the growth impairment in DS: growth hormone (GH) deficiency, gene alterations involving the GH‐IGF1 axis and disruption of specific brain structures during fetal development. This evidence concerns the gene GH1 and Dravet syndrome.